Compounded GLP-1 / GIP
For Him & Her
Weight loss

Compounded GLP-1 / GIP

Appetite, energy, and weight regulation can shift over time in ways that feel hard to explain. Hunger becomes harder to manage. Cravings feel more constant. Energy fluctuates. Progress no longer matches the effort. This is not just about discipline. Appetite and metabolism are heavily influenced by hormone signaling inside the body. Compounded GLP-1/GIP therapy is sometimes used as part of a medically supervised plan to support appetite regulation and metabolic function across multiple pathways.
$
199

/mo
4-month plan
Start your journey
Compounded GLP-1 / GIP and GLP-1  medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. They are not equivalent to FDA-approved products. Kingdom partners with licensed U.S. pharmacies that compound medications pursuant to valid prescriptions and applicable laws.
Who is it for?

It’s not just about willpower.

If hunger feels harder to control, cravings are more frequent, or energy feels inconsistent, there may be more going on beneath the surface. For many people, changes in metabolic signaling can affect appetite regulation, energy balance, and consistency over time, especially during periods of stress, hormonal shifts, aging, or lifestyle changes. Compounded GLP-1/GIP therapy may be worth discussing if managing appetite and maintaining consistency feels harder than it used to, even when you are doing the right things.
Fit man and woman in athletic wear standing confidently against a brown background with text 'Your peak performance, secured.'
Benefits
The pillars of your transformation
Support appetite regulation across pathways
Targets signals involved in hunger, satiety, and metabolic response.
Make consistency easier to maintain
Used as part of structured, provider-guided metabolic health plans.
Support metabolic function
Addresses systems involved in how the body processes and utilizes energy.
More stable day-to-day energy
Supports pathways tied to blood sugar regulation and energy balance.
The Science

Regulating appetite through dual hormone signaling.

GLP-1 and GIP are naturally occurring hormones involved in appetite control, digestion, glucose regulation, and energy metabolism. These incretin hormones help regulate hunger signaling, feelings of fullness, insulin response, and how the body processes nutrients after eating. Compounded GLP-1/GIP therapies are designed to act on both pathways simultaneously as part of a medically supervised metabolic health approach. GLP-1 primarily influences satiety and gastric emptying, while GIP plays a role in insulin signaling and nutrient utilization. Together, these pathways help regulate appetite, energy balance, and metabolic response through complementary mechanisms. At Kingdom, providers use lab work, health history, and clinical evaluation to determine whether this approach fits into a structured care plan.
The Clinical Journey

Guided by experts

Your treatment is not built from a template. Kingdom providers use lab work, health history, and ongoing check-ins to shape a protocol tailored to how your body responds over time.

Get Started
01
02
03

Take our quiz

Answer a few quick questions to help us understand your goals and medical history.

Meet your provider

Person having a video consultation with a doctor on a laptop showing a smiling male doctor in a white coat.

Meet with a specialized clinician who reviews your data and designs a strategy tailored to you.

Begin your journey

Receive your custom protocol at your doorstep with continuous clinical oversight to ensure your long-term success.

Explore More

Health is a Kingdom

Your optimization might go further. Discover how our other protocols can complement your wellness journey.
Hormone
Therapy
Vial of kingdom Testosterone Cypionate with red and white capsules labeled kingdom floating around it.
Wellness
Glass vial labeled Kingdom NAD+ with green cap, next to green tablets embossed with the letter K.
FAQS

For every question, an expert answer.

If your question isn't here, don't worry, Ask our experts for clarity on your journey. We’re here to help.

What makes dual-pathway therapy different from GLP-1 alone?

Targeting both GLP-1 and GIP receptors engages multiple pathways involved in appetite regulation, glucose metabolism, and energy use.

‍

Does GLP-1/GIP therapy affect digestion?

GLP-1 slows gastric emptying, which can extend satiety, while GIP influences how nutrients are processed after absorption.

‍

Who is typically considered for GLP-1/GIP therapy?

It is often discussed when appetite regulation, metabolic response, energy balance, or weight management remain challenging despite consistent lifestyle efforts.

‍

How do GLP-1 and GIP work together?

GLP-1 and GIP are incretin hormones that act on complementary metabolic pathways. GLP-1 primarily influences satiety and gastric emptying, while GIP plays a role in insulin signaling and nutrient utilization.

‍

How does GLP-1/GIP affect insulin response?

Both hormones enhance glucose-dependent insulin secretion, meaning insulin release is tied to food intake rather than occurring independently.

‍

How is therapy adjusted over time?

Dosing and protocol decisions are based on clinical response, tolerability, appetite changes, and metabolic markers, with ongoing monitoring built into the process.

‍

Why can cravings feel more constant over time?

Changes in metabolic signaling, stress, hormonal fluctuations, aging, and lifestyle factors can all influence hunger cues and reward-driven eating behaviors.

‍

Why is clinical supervision important with dual incretin therapy?

Because these therapies influence multiple metabolic systems, monitoring helps align treatment with individual response, tolerability, and overall health goals.

‍